200
Participants
Start Date
February 22, 2021
Primary Completion Date
January 9, 2023
Study Completion Date
January 9, 2023
Abemaciclib
Administered orally
Nonsteroidal Aromatase Inhibitor (NSAI)
Letrozole or anastrozole administered orally (physician choice)
Fulvestrant
Administered intramuscularly
Rajiv Gandhi Cancer Institute And Research Centre, New Delhi
Max Superspeciality Hospital, Chandigarh
Kailash Cancer Hospital & Research Centre (KCHRC), Waghodia
Nirmal Hospital Pvt Ltd., Surat
Unique Hospital Multispecialty & Research Institute, Surat
Ruby Hall Clinic and Grant Medical Foundation, Pune
HCG Manavata Cancer Centre, Nashik
Kingsway Hospital, Nagpur
Meditrina Institute of Medical Sciences, Nagpur
SRJ-CBCC Cancer Hospital, Indore
MNJ Institute of Oncology, Hyderabad
HCG Cancer Centre, Kalinga Rao Road, Bengaluru
Regional Cancer Centre, Trivandrum
Apollo Gleneagles Hospitals Kolkata, Kolkata
Indira Gandhi Institute of Medical Sciences, Patna
Eli Lilly and Company
INDUSTRY